VTVT logo

vTv Therapeutics Inc.

VTVT
Healthcare|Biotechnology|US
$21.03
-0.71 (-3.27%)
DCF Value
$10.43
Tangible Book / Share
$5.61
Cash / Share
$6.21
Next Earnings Report
Mar 9, 2027
EPS est. -$1.14
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest May 13, 2026 (424B2). Possible dilution.

Upcoming Data Readouts (1)

Apr 2027
Est. completion
P3Diabetes Mellitus, Type 1
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133n=150

Recent Press Releases

vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
Oct 27, 2026 · GlobeNewsWire
vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
Oct 7, 2026 · GlobeNewsWire
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
Oct 6, 2026 · GlobeNewsWire
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
Oct 5, 2026 · GlobeNewsWire
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Sep 15, 2026 · GlobeNewsWire
vTv Therapeutics to Participate in September Investor Conferences
Sep 2, 2026 · GlobeNewsWire
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 19, 2026 · GlobeNewsWire

SEC Filings (53)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jul 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 10, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 13, 2026424B2Offering prospectusDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
May 13, 2026S-8Employee stock planDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
Apr 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 16, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Mar 10, 202610-KAnnual reportDocumentIndex
Feb 26, 20268-KMaterial eventDocumentIndex
Feb 2, 20268-KMaterial eventDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex
Dec 9, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 24, 2025EFFECTDocumentIndex
Nov 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 3, 2025S-3Shelf registrationDocumentIndex
Sep 25, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 10, 20258-KMaterial eventDocumentIndex
Sep 8, 2025SC 13GPassive 5%+ stakeDocumentIndex
Sep 8, 2025SC 13GPassive 5%+ stakeDocumentIndex
Sep 3, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 2, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Jun 12, 20258-KMaterial eventDocumentIndex
May 19, 20258-KMaterial eventDocumentIndex
May 16, 20258-KMaterial eventDocumentIndex